Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
WittGen Biotechnologies
WittGen Bio leverages AI to analyze single-cell data, aiming to uncover new cancer therapeutic opportunities. Their platform, LEIBER-X, is designed to identify novel targets and biomarkers, monitor…
WittGen Biotechnologies
WittGen Bio leverages AI to analyze single-cell data, aiming to uncover new cancer therapeutic opportunities. Their platform, LEIBER-X, is designed to identify novel targets and biomarkers, monitor…
TL;DR
Founded: 2023 (Berkeley, CA)
Product: LEIBER-X — AI platform that generates single-cell–level insights from bulk RNA‑seq and pathology images
Focus: Oncology: targets, biomarkers, responder prediction, and regulator-ready patient stratification
Funding: Seed round announced 2023-06-06; lead investor Plug and Play (amount undisclosed)
Investors / Supporters: Primer, Hatcher+, Plug and Play Tech Center
Team size: ~7 employees
Company Overview
Problem Domain
Oncology drug discovery and clinical development — identifying targets and biomarkers, predicting responders, and optimizing clinical trial enrollment/stratification.
Founded
2023
Industry
Biotechnology
Tech Stack
Funding Track Record
Amount undisclosed
Investor Signal
“Backed by Primer, Hatcher+, and Plug and Play Tech Center; Plug and Play led the announced Seed round (2023-06-06).”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
58,000+
Open Roles
2,700+
New This Week